VTV THERAPEUTICS INC.
Profile
Company Names
VTV THERAPEUTICS INC.
Addresses
3980 PREMIER DR, SUITE 310, HIGH POINT, NC 27265
3980 PREMIER DRIVE, SUITE 310, HIGH POINT, NC 27265
4170 MENDENHALL OAKS PKWY, HIGH POINT, NC 27265
Phone Numbers
336-841-0300
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$70,461,457.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-02-27
$50,961,457.00
$50,961,457.00
$0.00
Equity
5
2020-01-07
$2,000,000.00
$10,000,000.00
$8,000,000.00
Equity
4
2019-09-27
$2,000,000.00
$10,000,000.00
$8,000,000.00
Equity
3
2019-06-25
$4,000,000.00
$9,000,000.00
$5,000,000.00
Equity
2
2018-12-27
$1,500,000.00
$10,000,000.00
$8,500,000.00
Equity
1
2017-12-05
$10,000,000.00
$10,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SRINIVAS
AKKARAJU
DIRECTOR
SEATTLE GENETICS INC /WA
| PRESIDIO PHARMACEUTICALS, INC.
| VERSARTIS, INC.
| PRINCIPIA BIOPHARMA INC.
| SYROS PHARMACEUTICALS, INC.
| SAMSARA BIOCAPITAL, L.P.
| 565 SPV I, L.P.
| TENTARIX BIOTHERAPEUTICS, LP
| CHINOOK THERAPEUTICS U.S., INC.
| MINERALYS THERAPEUTICS, INC.
| ORSOBIO, INC.
| VTV THERAPEUTICS INC.
| ALUMIS INC.
| SAMSARA OPPORTUNITY FUND, L.P.
STEVEN
COHEN
DIRECTOR
JOHN
FRY
DIRECTOR
RUDY
HOWARD
EXECUTIVE OFFICER
JEFFREY
KINDLER
DIRECTOR, EXECUTIVE OFFICER
PAUL
MEISTER
DIRECTOR
MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| QUANTERIX CORP
| GCM GROSVENOR CALIFORNIA IMPACT SBIC FUND, L.P.
| CIC-FPRT ABSOLUTE RETURN PORTFOLIO, LTD.
| SAN GABRIEL FUND 3, L.P.
| GCM PATRIOT, LLC
| GCM GROSVENOR OPPORTUNISTIC CREDIT FUND V, LTD.
| GCM TRIBE, LLC
| TITANIUM F2 FUND, LTD
| GCM RANGER, LLC
| GROSVENOR OPPORTUNISTIC MULTI-STRATEGY FUND, L.P.
| GROSVENOR INSTITUTIONAL PARTNERS (PF), LTD.
| GCM GROSVENOR SPECIAL OPPORTUNITIES FUND, L.P.
| VTV THERAPEUTICS INC.
| MCG ALTSCAPE FUND, L.P
| KUMANU, INC.
| ACTIV SURGICAL, INC.
| MERCY BIOANALYTICS, INC.
| ARBOR BIOTECHNOLOGIES, INC.
| LUMACYTE, INC.
| NOVALIS LIFESCIENCES INVESTMENTS II, L.P.
| PERFECT AIR HOLDCO LLC
| PANTHER MANAGEMENT HOLDCO LLC
| LEVITASBIO, INC.
| UPKARA INC.
| TELESIS BIO INC.
| AMBIENT BIOSCIENCES, INC.
| BLUEWHALE BIO, INC.
| FLYWHEEL EXCHANGE INC.
| GCM GROSVENOR CREDIT SECONDARIES STRUCTURED NOTE 2025, L.P.
| GCM GROSVENOR CREDIT SECONDARIES STRUCTURED NOTE 2025 FEEDER, L.P.
| EVEREST BIOLABS, INC.
RICHARD
NELSON
EXECUTIVE OFFICER, DIRECTOR
CRAIG
PARKER
DIRECTOR
PAUL
J.
SEKHRI
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-02-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-01-07
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-09-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-06-25
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-12-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-12-05
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

